The metabolic hormone FGF21 is associated with endothelial dysfunction in hemodialysis patients.
Rusu CC, Racasan S, Kacso IM, Moldovan D, Potra A, Tirinescu D, Budurea C, Orasan R, Patiu IM, Bondor CI, Vladutiu D, Caprioara MG.
Rusu CC, et al. Among authors: kacso im.
Int Urol Nephrol. 2017 Mar;49(3):517-523. doi: 10.1007/s11255-016-1474-x. Epub 2016 Dec 10.
Int Urol Nephrol. 2017.
PMID: 27943169